Harmala alkaloids and related β-carbolines: A myoclonic model and antimyoclonic drugs
- 1 June 1987
- journal article
- research article
- Published by Elsevier in Experimental Neurology
- Vol. 96 (3), 703-719
- https://doi.org/10.1016/0014-4886(87)90231-7
Abstract
No abstract availableThis publication has 42 references indexed in Scilit:
- The benzodiazepine antagonist Ro 15–1788 reverses the effect of methyl-β-carboline-3-carboxylate but not of harmaline on cerebellar cGMP and motor performance in miceEuropean Journal of Pharmacology, 1985
- Characterization of convulsions induced by methyl β-carboline-3-carboxylate in miceEuropean Journal of Pharmacology, 1984
- Ligands for benzodiazepine receptors with positive and negative efficacyBiochemical Pharmacology, 1984
- Intrinsic actions of benzodiazepine antagonistsNeuroscience Letters, 1982
- .beta.-Carbolines: synthesis and neurochemical and pharmacological actions on brain benzodiazepine receptorsJournal of Medicinal Chemistry, 1982
- Inhibition of benzodiazepine receptor binding by several tryptophan and indole derivativesBiochemical Pharmacology, 1981
- Serotonin receptor interactions of harmaline and several related β-carbolinesLife Sciences, 1981
- Inhibition by β-carbolines of monoamine uptake into a synaptosomal preparation: Structure-activity relationshipsLife Sciences, 1977
- The importance of 5-hydroxytryptamine for the induction of harmine tremor and its antagonism by dopaminergic agonists assessed by lesions of the midbrain raphe nucleiEuropean Journal of Pharmacology, 1976
- An investigation on the central effects of harmine, harmaline and related β-carbolinesNeuropharmacology, 1971